S. Africa Discourages Use of Parasite Drug Ivermectin in COVID-19 Patients Outside Trials

Jan 29, 2021 | EARNINGS

JOHANNESBURG (Sputnik) – South Africa’s Department of Health has recommended against the use of parasite drug ivermectin in COVID-19 patients unless it is given in controlled trials, citing a lack of knowledge about its safety and effectiveness in coronavirus treatment.

Read More

Pin It on Pinterest